Prior to the widespread clinical use of TSH and thyroid hormone radioimmunoassays, physicians relied on measurable bio-metabolic parameters to determine the appropriate dose of thyroid hormone replacement for patients with hypothyroidism. This evidence concerns the gene TG and hypothyroidism.